Showing 41-50 of 1378 results for "".
What's the most important thing you do each morning to start your day?
https://practicaldermatology.com/topics/general-topics/what-s-the-most-important-thing-you-do-each-morning-to-start-your-day--xvibvixd/18551/Besides drinking a large cup of coffee, listen to what Terrence Keaney, MD says he makes sure to do every morning that helps him maintain a good work-life balance.Content Curation: What to Know
https://practicaldermatology.com/topics/practice-management/content-curation-what-to-know/18761/Content curation can increase web exposure for medical practices. It's a tool for good SEO. In this Ekwa Educational video, you'll learn how to curate content effectively for optimal benefit.Innovation in Dermatology Entrepreneurship
https://practicaldermatology.com/topics/practice-management/innovation-in-dermatology-entrepreneurship/18912/Entrepreneurship in dermatology is "in a good spot," says William Ju, MD, President of Advancing Innovation in Dermatology. Dermatology is a high-growth field, supported by patient demand and globalization and scientific advancements.The View from Under the Hood
https://practicaldermatology.com/issues/january-february-2025/the-view-from-under-the-hood/32967/As 2025 brings new approvals for treatments for hidradenitis suppurativa, chronic spontaneous urticaria, psoriatic arthritis, and several other diseases that need answers, this is a good time for us to remember that the most important approach to treatment starts with the right diagnosis.Vitiligo: Current and Future Developments
https://practicaldermatology.com/conferences/maui-derm-2020/vitiligo-current-and-future-developments/19722/John E. Harris, MD, PhD reviews treatment advances and emerging science in vitiligo. From new topical agents to intriguing studies on a potential role for biologics, there is very good reason to be optimistic about the future of vitiligo treatment.FDA Warns on Expression; Lilly's Ixekizumab Data Promising
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-warns-on-expression-lilly-s-ixekizumab-data-promising/19093/Lilly's Ixekizumab phase III data look good for psoriasis, and the FDA warns on improper use of Expression hyaluronic acid as a dermal filler. Plus, Sitavig is available for herpes labialis, and Syneron's laser gets an onychomycosis clearance.What's New In Retirement Planning?
https://practicaldermatology.com/topics/practice-management/whats-new-in-retirement-planning/21249/Defined benefit plans can provide larger tax deductions than 401(k)s/profit-sharing plans.Intergenerational Dermatology: Three Generations of Dermatologists Reflect on the Field
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatology-three-generations-of-dermatologists-reflect-on-the-field/23992/With Sorrel S. Resnik, MD, Barry Resnik, MD, and Sydney Resnik, MD, by Heidi SpletePearls from NYC: Oy Vey!
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pearls-from-nyc-oy-vey-/18752/By Gary Goldenberg, MD and Seemal R. Desai, MDWhat happens if you shave a melanoma? Dr. Goldenberg addresses a common question from the clinic. The good news? The type of biopsy done does not appear to affect long-term survival in melanoma.To Be Shorr: Your receptionist is director of first impressions
https://practicaldermatology.com/topics/practice-management/to-be-shorr-your-receptionist-is-director-of-first-impressions/18603/Th best physicians and surgeons can see their practice fall apart if they lack good staff. The receptionist is often the first contact a patient has with your practice. Think of this individual as your director of first impressions, says Mara Shorr, BS, CAC II-V.